D-Cycloserine, powder
Application
D-Cycloserine (DCS) has been used:to study its effect on partner preference in Prairie Volesto study its effect on grooming behaviour of ratsto determine its minimum inhibitory concentration (MIC) on 48 multidrug resistant tuberculosis (MDR-TB) isolates using the broth microdilution methodto study its effect on mouse model of autism, using behavioural assays
Biochem/physiol Actions
D-cycloserine (DCS) was initially known as a tuberculostatic agent. It acts as a glutamatergic partial N-methyl-D-aspartate (NMDA) agonist. It binds at the glycine-binding site of the NMDA receptor and enable the opening of the NMDA channel. DCS has a an ability to improve various forms of learning and memory hence, this drug might be effective for improving social memory and cognition. DCS can be used as a potential therapeutic for psychiatric disorders such as phobias, social anxiety, obsessive-compulsive disorder, and posttraumatic stress disorder.
Mode of Action: Inhibits cell wall biosynthesis (D-Ala peptide bond formation). Also prevents conversion of D-Ala to L-Ala. Bacteriostatic.Partial agonist at the glycine modulatory site of NMDA glutamatergic receptors; antibiotic against Gram-negative bacteria.Mode of Resistance: D-Ala transport interference.
General description
Chemical structure: amino acid derivatives
Packaging
1, 5 g in poly bottle
| Quality Level | 200 |
|---|---|
| mp | 147 °C (dec.) (lit.) |
| InChI key | DYDCUQKUCUHJBH-UWTATZPHSA-N |
| InChI | 1S/C3H6N2O2/c4-2-1-7-5-3(2)6/h2H,1,4H2,(H,5,6)/t2-/m1/s1 |
| Manufacturer | SIGMA-ALDRICH |
| Form | powder |
There are no downloads for this product.